Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001731122-23-000271
Filing Date
2023-02-27
Accepted
2023-02-27 16:16:57
Documents
71
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e4443_10k.htm   iXBRL 10-K 1718369
2 EXHIBIT 4.3 e4443_ex4-3.htm EX-4.3 20202
3 EXHIBIT 21.1 e4443_ex21-1.htm EX-21.1 3407
4 EXHIBIT 23.1 e4443_ex23-1.htm EX-23.1 3107
5 EXHIBIT 31.1 e4443_ex31-1.htm EX-31.1 15391
6 EXHIBIT 31.2 e4443_ex31-2.htm EX-31.2 14904
7 EXHIBIT 32.1 e4443_ex32-1.htm EX-32.1 6027
8 EXHIBIT 32.2 e4443_ex32-2.htm EX-32.2 5311
9 GRAPHIC image_001.jpg GRAPHIC 111181
  Complete submission text file 0001731122-23-000271.txt   7270716

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE enob-20220630.xsd EX-101.SCH 48985
11 XBRL CALCULATION FILE enob-20220630_cal.xml EX-101.CAL 57770
12 XBRL DEFINITION FILE enob-20220630_def.xml EX-101.DEF 192342
13 XBRL LABEL FILE enob-20220630_lab.xml EX-101.LAB 395741
14 XBRL PRESENTATION FILE enob-20220630_pre.xml EX-101.PRE 321034
65 EXTRACTED XBRL INSTANCE DOCUMENT e4443_10k_htm.xml XML 994832
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-38758 | Film No.: 23675099
SIC: 2834 Pharmaceutical Preparations